Meet Thoracic Surgeon Matthew Bott
Meet Thoracic Surgeon Matthew Bott
Matthew Bott, MD
Surgeon
Titles
Assistant Attending Surgeon
Clinical Expertise
Lung and Esophageal Cancers; Thymic Malignancies; Pulmonary Metastases; Minimally Invasive Surgery; Video-Assisted Thoracic Surgery (VATS); Endobronchial Ultrasound (EBUS); Robotic Bronchoscopy; Minimally Invasive Lung Biopsy
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Bott accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type:
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): PPO, HMO
Payor Type:
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type:
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type:
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type:
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type:
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Contact and Location
- 212-639-5944 Office Phone
- Speaks English
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, University of Virginia
Residencies
General Surgery - NewYork-Presbyterian Hospital/Weill Cornell Medical Center
Fellowships
Cardiothoracic Surgery - Washington University School of Medicine in St. Louis/Barnes-Jewish Hospital; Research Fellowship - Memorial Sloan Kettering Cancer Center
Board Certifications
General Surgery; Cardiothoracic Surgery
I am a surgeon who specializes in treating cancers of the chest, including lung cancer, esophageal cancer, thymic tumors, and neuroendocrine tumors. I have experience using the latest technology to diagnose and treat a wide variety of thoracic diseases of the lung, esophagus, and chest wall. I also have expertise in treatments for benign conditions including anti-reflux procedures and hiatal hernia repair.
Read more
I see about 1,000 patients per year. Most are concerned about their outcomes following cancer treatment and how it will impact their lives moving forward. I try to reassure them by explaining that we offer a number of treatment options that not only offer good long-term outcomes but also help people heal quickly so they can return to their daily activities. I perform most operations using minimally invasive techniques, which require smaller incisions and have been shown to minimize discomfort and speed up recovery.
I chose to become a thoracic cancer surgeon because surgery can often offer the highest likelihood of a cure for people with early stage disease. In fact, people with early stage lung cancer can often be successfully treated with minimally invasive surgery and other techniques that have a lower long-term impact on their breathing and overall health. I also focus on techniques and procedures to improve symptoms and quality of life in people with advanced cancer. Working with my colleagues in medical and radiation oncology, we offer treatment plans that are unique and tailored to each patient’s needs.
MSK is a world leader in developing and refining new approaches to care for people with cancer. There are a number of exciting developments in the treatment of lung and esophageal cancer. Immunotherapy, which was pioneered at MSK, has become an important treatment option and I am co-investigator on a number of clinical trials to evaluate its effectiveness prior to surgery in people with early stage disease. We are also performing lung biopsies using newer techniques such as robotic bronchoscopy, which is extremely safe and effective.
A significant portion of my time is spent conducting scientific research to better understand how tumors form and investigating new ways to treat them. Using a patient-centered approach, I am working to design new models to study cancer and then use these experimental models to develop better treatments. It is my hope that discoveries made in the laboratory will result in more-effective therapies and will ultimately help to cure people afflicted by thoracic diseases.
Outside of work I enjoy spending time with my family. My children are active in a variety of sports such as baseball and soccer as well as scouting. We also enjoy outdoor activities like skiing, hiking, fishing, and running, and have even completed two marathons with my wife.
I am especially fond of traveling, periodically visiting family in Germany and France and exploring places like Peru, Vietnam, Cambodia, Australia, and China. In medical school I participated in a mission trip to Ghana to deliver medical care to remote villages.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Bott
- A Phase I/IIA Study of ATL001 with or without Pembrolizumab Immunotherapy in People with Non-Small Cell Lung Cancer
- A Phase II Study of Targeted Radiation Therapy for People with Non-Small Cell Lung Cancer that Spread to the Liver
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Bott’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Matthew Bott discloses the following relationships and financial interests:
-
AstraZeneca
Provision of Services
-
Intuitive Surgical Inc.
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].